Dergi makalesi Açık Erişim
Yakubogullari, Nilgun; Coven, Furkan Ozan; Cebi, Nusin; Coven, Fethiye; Coven, Nejdet; Genc, Rukan; Bedir, Erdal; Nalbantsoy, Ayse
<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
<identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/233224</identifier>
<creators>
<creator>
<creatorName>Yakubogullari, Nilgun</creatorName>
<givenName>Nilgun</givenName>
<familyName>Yakubogullari</familyName>
<affiliation>Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35433 Izmir, Turkey</affiliation>
</creator>
<creator>
<creatorName>Coven, Furkan Ozan</creatorName>
<givenName>Furkan Ozan</givenName>
<familyName>Coven</familyName>
<affiliation>Manisa Celal Bayar Univ, Fac Engn, Dept Bioengn, TR-45140 Manisa, Turkey</affiliation>
</creator>
<creator>
<creatorName>Cebi, Nusin</creatorName>
<givenName>Nusin</givenName>
<familyName>Cebi</familyName>
<affiliation>Ege Univ, Fac Engn, Dept Bioengn, TR-35100 Izmir, Turkey</affiliation>
</creator>
<creator>
<creatorName>Coven, Fethiye</creatorName>
<givenName>Fethiye</givenName>
<familyName>Coven</familyName>
<affiliation>Bornova Vet Control Inst, TR-35100 Izmir, Turkey</affiliation>
</creator>
<creator>
<creatorName>Coven, Nejdet</creatorName>
<givenName>Nejdet</givenName>
<familyName>Coven</familyName>
<affiliation>Bornova Vet Control Inst, TR-35100 Izmir, Turkey</affiliation>
</creator>
<creator>
<creatorName>Genc, Rukan</creatorName>
<givenName>Rukan</givenName>
<familyName>Genc</familyName>
<affiliation>Mersin Univ, Fac Engn, Dept Chem Engn, TR-33343 Mersin, Turkey</affiliation>
</creator>
<creator>
<creatorName>Bedir, Erdal</creatorName>
<givenName>Erdal</givenName>
<familyName>Bedir</familyName>
<affiliation>Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35433 Izmir, Turkey</affiliation>
</creator>
<creator>
<creatorName>Nalbantsoy, Ayse</creatorName>
<givenName>Ayse</givenName>
<familyName>Nalbantsoy</familyName>
<affiliation>Ege Univ, Fac Engn, Dept Bioengn, TR-35100 Izmir, Turkey</affiliation>
</creator>
</creators>
<titles>
<title>Evaluation Of Adjuvant Activity Of Astragaloside Vii And Its Combination With Different Immunostimulating Agents In Newcastle Disease Vaccine</title>
</titles>
<publisher>Aperta</publisher>
<publicationYear>2021</publicationYear>
<dates>
<date dateType="Issued">2021-01-01</date>
</dates>
<resourceType resourceTypeGeneral="Text">Journal article</resourceType>
<alternateIdentifiers>
<alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/233224</alternateIdentifier>
</alternateIdentifiers>
<relatedIdentifiers>
<relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1016/j.biologicals.2021.01.005</relatedIdentifier>
</relatedIdentifiers>
<rightsList>
<rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
<rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
</rightsList>
<descriptions>
<description descriptionType="Abstract">Astragaloside VII (AST-VII), a major cycloartane saponin isolated from Turkish Astragalus species, turned out to be one of the most active metabolites demonstrating Th1/Th2 balanced immune response. As Quillaja saponins are extensively used in adjuvant systems, this study made an attempt to improve AST-VII based adjuvant systems by using different immunostimulatory/delivery agents (monophosphoryllipid A (MPL), Astragalus polysaccharide (APS) and squalene) and to induce cellular and humoral immune response against a viral vaccine. For this purpose, Newcastle Disease vaccine (NDV) was chosen as a model vaccine. Swiss albino mice were immunized subcutaneously with LaSota vaccines in the presence/absence of AST-VII or developed adjuvant systems. AST-VII administration both in live/inactivated LaSota vaccines induced neutralizing and NDV specific IgG, IgG1 and IgG2b antibodies response as well as IL-2 and IL-4 production. APS based delivery systems enhanced the production of neutralizing antibody and the minor augmentation of IFN-? and IL-2 levels. Squalene emulsion (SE) alone or combined with AST-VII were effective in NDV restimulated splenocyte proliferation. As a conclusion, AST-VII and AST-VII containing adjuvant systems demonstrated Th1/Th2 balanced antibody and cellular immune responses in NDV vaccines. Thus, these systems could be developed as vaccine adjuvants in viral vaccines as alternative to saponin-based adjuvants.</description>
</descriptions>
</resource>
| Görüntülenme | 28 |
| İndirme | 7 |
| Veri hacmi | 2.0 kB |
| Tekil görüntülenme | 26 |
| Tekil indirme | 7 |